Article
Disease burden at the progenitor level is a feature of primary myelofibrosis: a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients.
Experimental hematology - 1 Jan 2011
Stein Brady L, Williams Donna M, Rogers Ophelia, Isaacs Mary Ann, Spivak Jerry L, Moliterno Alison R
Abstract excerpt
OBJECTIVE: Suppression of normal hematopoiesis by the neoplastic clone (clonal dominance) is a feature of the myeloproliferative neoplasms, but the determinants that predict clonal dominance are unknown. The objective of this study was to identify clinical and laboratory variables that associate with the JAK2 V617F CD34(+) progenitor allele burden and clonal dominance, which was defined by congruence of the JAK2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
